Browse Category

Financial Trends News 13 October 2025 - 27 October 2025

Rigetti’s Quantum Leap: Stock Jumps 5,000% and Then Grinds Back – Bubble or Breakthrough?

Rigetti’s Quantum Stock Explosion: 5,000% Surge, Sudden Slump, and What’s Next for RGTI

Record Surge and Wild Volatility Rigetti Computing’s stock has been on a rollercoaster ride in 2025. At the start of the year, RGTI traded for mere cents. By October 15, it had rocketed to a record closing high of $56.34ts2.tech, an almost 50-fold increase in under 10 months. In the week leading up to that peak, Rigetti’s share price exploded…
GM Stock Soars 19% on Surprising Earnings Beat – What’s Driving the Rally?

GM Stock Soars 19% on Surprising Earnings Beat – What’s Driving the Rally?

GM stock surged about 19% in the week ending Oct 24, 2025, closing at roughly $69.66 gmauthority.com, its highest level ever. This jump came after General Motors’ strong third-quarter earnings (EPS of $2.80 vs. $2.31 expected) and upbeat guidance reuters.com news.gm.com. Management raised full-year profit forecasts (now $12.0–13.0 billion EBIT vs. $10.0–12.5B prior) and lowered projected tariff costs to $3.5–4.5 billion reuters.com…
AI Stock Boom or Bubble? Tech Rally Soars as Experts Warn of Risk

Supermicro Stock Plunges 8% as AI Server Boom Hits a Snag – What’s Next for SMCI?

Shares Slump on a Surprise Revenue Warning Supermicro (NASDAQ: SMCI) shares tumbled on Thursday, October 23, after the server maker issued a surprise revenue warning for its current quarter. The company revealed that first-quarter fiscal 2026 revenue would come in around $5 billion, well below its earlier $6–7 billion outlookreuters.com. The announcement – which cited “design win upgrades” and customer delivery schedule…
Ventyx Biosciences (VTYX) Stock Rockets on Breakthrough Inflammation Study – Analysts Bullish

Ventyx Biosciences (VTYX) Stock Rockets on Breakthrough Inflammation Study – Analysts Bullish

Stock Performance and Recent Rally Ventyx Biosciences has been one of 2025’s biggest small-cap biotech movers. The Nasdaq-listed stock jumped sharply on Oct. 22 after hours, when the company announced the positive Phase 2 data. On Oct. 22 regular trading, VTYX ended at $3.86 (up +2.66% that day) marketbeat.com, but in electronic after-hours trading it skyrocketed roughly 85–90%, touching the…
Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?

Gold’s Epic Rally Ends With a Shock Slump: What’s Next for Bullion?

Record-Highs to Rout: Gold’s Recent Rollercoaster After months of safe-haven buying and Fed-cut bets, gold blasted off this year – from ~$2,700 in Jan to over $4,000/oz by early October ts2.tech reuters.com. Factors included an embattled U.S. economy (shutdown, debt ceiling), geopolitical strife (Middle East, China-US trade tensions), and aggressive Fed easing expectations reuters.com ts2.tech. Central banks from China to…
Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Praxis Precision Medicines (PRAX) Stock Skyrockets 180% on Game‑Changing Trial – Analysts See ‘Blockbuster’ Upside

Record Stock Surge on Phase 3 Breakthrough Praxis Precision Medicines shares skyrocketed on October 16, 2025, after the biotech reported game-changing Phase 3 trial results for its essential tremor drug. The stock closed that Thursday at $162.71, up over 183% in a single daymedcitynews.com. Earlier that morning, Praxis announced that ulixacaltamide – its experimental therapy for essential tremor – had succeeded…
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s Wild Ride: Soars on Record Deliveries, Then Sags After Budget EV Reveal

Tesla’s mid-October stock action reflects this mix of good news and looming questions. On Oct 16, 2025, TSLA traded roughly flat in the mid-$430s (around $430 by mid-afternoon)reuters.com. That mild move belied a wildly volatile week. After hitting multi-month highs around $453 in early October, Tesla gave back ground on profit-taking. “Tesla’s stock has seesawed sharply,” noted our research: it…
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Skyrockets 75% on $40M Oil Deal – Bulls and Bears Debate What’s Next

Oil Deal Sparks Surging Stock Price Vivakor’s mid-October rally was ignited by news of a major funding deal aimed at boosting its oil trading business. On October 15, the Dallas-based energy services firm revealed it had signed a term sheet for a $40 million commodity intermediation credit facility with an undisclosed wholesale credit providerts2.tech. The facility is designed to support…
Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

Vivakor (VIVK) Stock Surges 75% After $40M Oil Trading Deal – Bulls & Bears Weigh In

In mid-October Vivakor’s stock surged amid fresh corporate deals. On Oct. 15 the company revealed it had signed a non-binding term sheet for a $40M commodity intermediation facilityglobenewswire.com. This arrangement (with a wholesale credit provider) is intended to underwrite letters of credit, bonds or cash deposits to support Vivakor Supply & Trading, LLC’s physical crude oil purchasesglobenewswire.com. CEO James Ballengee…
Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally?

Sana Biotech Shares Skyrocket on 100x Hype – What’s Behind the Rally?

Stock Surge Fueled by ‘100-Bagger’ Tweet On Oct. 15, SANA spiked as investors reacted to hedge fund manager Eric Jackson’s bullish call. In a post on X (formerly Twitter), Jackson proclaimed: “Biotech is back. Rates are falling, inflation is cooling, and money is rotating from megacaps to growth again,” and suggested “$SANA looks like the next 100-Bagger platform”benzinga.com. Benzinga and…
Caterpillar Stock Soars to Record High After $650 Upgrade and Strategic Deals

Caterpillar Stock Soars to Record High After $650 Upgrade and Strategic Deals

Stock Soars on Upbeat News and Market Momentum Caterpillar’s stock price surged on Tuesday, buoyed by positive analyst commentary and strategic news. The stock climbed about 4.5% intraday to as high as $528.45ainvest.com, before settling slightly below that level by the closing bell. This marks Caterpillar’s highest share price ever, extending a rally that has seen the industrial icon’s stock…
Markets in Limbo: Stocks Soar on Trade Truce Hopes – But Is a Pullback Imminent?

Markets in Limbo: Stocks Soar on Trade Truce Hopes – But Is a Pullback Imminent?

Market Snapshot and Reactions Last Week’s Close: U.S. indices ended sharply lower on Friday, Oct 10 (the last trading day). The Dow Jones Industrials fell 878.82 points (−1.9%) to 45,479.60 nasdaq.com. The tech-heavy Nasdaq Composite plunged 820.20 points (−3.6%) to 22,204.43 nasdaq.com — its steepest drop since April 10. The S&P 500 lost 182.60 points (−2.7%) to 6,552.51, its largest…

Stock Market Today

  • Deinove SA (ALDEI.PA) Sees 13 Million Shares Traded Amid Volatility on EURONEXT
    February 6, 2026, 10:32 AM EST. Deinove SA (ALDEI.PA) topped EURONEXT's intraday volume charts Monday, with 13.01 million shares exchanging hands, more than double its average daily volume. The microcap biotech stock traded between €0.02 and €0.03, closing near €0.0265, reflecting heightened speculative interest amid thin liquidity. Deinove's market cap stands at roughly €1.13 million. Despite negative earnings per share and a high enterprise-to-sales ratio, increased volume signals short-term buying pressure above the 50-day average price of €0.02. Meyka AI assigns a 'Hold' rating and forecasts an upside potential to €0.05, although risks remain from ongoing cash burn and microcap volatility. Traders eye support at €0.01 and resistance near €0.44 in this cautious, high-risk environment.
Go toTop